Gynaecology: Menopause Flashcards

1
Q

What is menopause?

A

Cessation of menstruation for 12 months due to loss of ovarian follicular activity (retrospective diagnosis made after cessation of period for 12 months)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the average age of menopause?

A

51 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the perimenopause?

A

Perimenopause is the time around menopause where they may be experiencing vasomotor symptoms & irregular periods; it includes time leading up to last menstrual period and the 12 months afterwards. Typically in women >45yrs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the postmenopause?

A

Period from 12 months after the final menstrual period onwards.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is premature menopause and what is the cause?

A

Menopause before 40yrs due to premature ovarian insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Discuss the pathophysiology of menopause

A
  • In ovaries, process of primordial follicles maturing into primary & secondary follicles is always occurring independent of menstrual cycle
  • At start of cycle, FSH binds to FSH receptors on secondary follicle causing further development of secondary follicles into antral follicles (see repro recap FC for more)
  • Granulosa cells that surround follicles secretes oestrogen
  • In menopause, there is a decline in the development of ovarian follicles
  • Decline in follicular development results in decline in oestrogen production (by granulosa cells)
  • Decline in oestrogen stops negative feedback to the pituitary hence get increase in LH and FSH
  • Failing follicular development lead to anovulation and lack of oestrogen means endometrium doesn’t develop hence get lack of menstruation
  • Low oestrogen levels cause perimenopause symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

State some symptoms women may experience during the perimenopause & menopause

A
  • Vasomotor symptoms
    • Hot flushes
    • Night sweats
  • Mood & cognition changes
    • Emotional liability
    • Low mood
    • Poor concentration
  • Urogenital changes
    • Vaginal dryness
    • Urinary frequency
    • Frequent UTIs
  • Sexual dysfunction
    • Vaginal dryness
    • Reduced libido
  • Irregular periods
  • Joint pains
  • Headache
  • Fatigue
  • Sleep disurbance
  • PMS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is the menopause diagnosed?

A
  • Diagnosis can be made clinically (without any investigations) in women >45yrs with typical symptoms
  • Can use FSH blood test to aid diagnosis; recommended to use in situation such as:
    • Women <40yrs with suspected premature menopause
    • Women aged 40-45yrs with menopausal symptoms or change in menstrual cycle
    • Women >45ys with atypical symptoms
    • Women >50yrs on progesterone only contraception

Note: the Faculty of Sexual and Reproductive Healthcare (FSRH) states that a single elevated serum FSH level (more than 30 IU/L) indicates a degree of ovarian insufficiency, but not necessarily sterility. The British Menopause Society (BMS) recommends checking for an elevated FSH level on two blood samples taken 4–6 weeks apart.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diagnosing menopause in women taking hormonal contraception can be difficult; true or false?

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What would you expect the following levels to be during perimenopause/menopause:

  • Oestrogen
  • Progesterone
  • FSH
  • LH
A
  • Oestrogen: low
  • Progesterone: low
  • FSH: high
  • LH: high
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Discuss the guidance surrounding contraception & the menopause

A

Women need to use contraception for:

  • 2yrs after last menstrual period if LMP was when <50yrs
  • 1yr after last menstrual period if LMP was when >50yrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Discuss the management of menopause- ensure you categorise your answers to help you remember it

A

Can split management into 3 categories:

Lifestyle modification/advice

  • Hot flushes → regular exercise, weight loss, avoiding triggers e.g. caffeine/spicy foods/alcohol, light clothing, well ventilated room
  • Mood → regular exercise, relaxation, sleep
  • Sleep disturbance → avoid late-evening exercise, good sleep hygiene
  • Cognitive symptoms → regular exercise, sleep
  • Advice on contraception (HRT does not act as contraception)
  • Increased CVD risk → weight loss, smoking cessation, regular exercise, healthy balanced diet
  • Osteoporosis risk → weight bearing exercise, balanced diet, adequate vitamin D

Non-hormonal treatments

  • Vasomotor symptoms → clonidine, SSRIs (e.g. fluoxetine, citalopram), SNRIs (e.g. venlafaxine)
  • Psychological symptoms → self-help resources & groups, CBT, antidepressants (if confirmed diagnosis of depression or anxiety)
  • Urogenital symptoms/vaginal dryness → moisturisers (e.g. Replens), lubricants

HRT

  • Vasomotor symptoms:
    • Uterus: oral or transdermal combined HRT (oestrogen & progesterone)
    • No uterus: oral or transdermal oestrogen only HRT
  • Urogenital symptoms:
    • First line= low dose vaginal oestrogen (can be used alongside systemic HRT and moisturisers and lubricants)
  • Reduced libido
    • Can use testosterone (usually a gel or cream)
  • Mood disorders
    • Oral or transdermal HRT (following same rules as stated in vasomotor symptoms)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

For clonidine, discuss:

  • Mechanism of action
  • What it is useful for in menopause
  • Common side effects
A
  • Agonist of alpha-2 adrenergic receptors and of imidazoline receptors in the brain. Lowers BP and decreases HR
  • Helpful for vasomotor symptoms
  • Common side effects:
    • Dry mouth
    • Headaches
    • Constipation
    • Dizziness
    • Fatigue
    • Sudden withdrawal → rapid increase BP and agitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

State some potential complications/risks associated with the menopause due to lack of oestrogen

A
  • Increased risk cardiovascular disease
  • Increased risk stroke
  • Osteoporosis
  • Pelvic organ prolapse
  • Urinary incontinence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When and why is HRT used?

A

HRT used in perimenopausal and postmenopausal women to alleviate symptoms associated with menopause due to low oestrogen levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which women should go on cyclical HRT and which should go on continuous HRT?

A
  • Cyclical HRT: for women that still have periods, or haven’t had 12 months without periods
  • Continuous HRT: for women who are post-menopaual (e.g. not had period for 12 months or more)
  • ???You can switch from* cyclical to continuous HRT after at least 12 months of treatment in women over 50, and 24 months in women under 50 (not sure where this has come from). Switch from cyclical to continuous HRT during the withdrawal bleed. Continuous HRT has better endometrial protection than cyclical HRT.
  • *NOTE: cyclical combined HRT you take continuous oestrogen with progesterone added for specific periods during cycle (e.g. 1 monthly or 3 monthly). For continuous combined HRT you take both oestrogen & progesterone throughout.*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Explain why women with a uterus must have HRT with oestrogen and progesterone

A

To prevent endometrial hyperplasia and endometrial cancer due to unopposed oestrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

State some indications for HRT

A
  • Replacing hormones in premature ovarian insufficiency (even if pt not having troublesome symptoms. Should continue to give until age of 50yrs)
  • Reducing vasomotor symptoms (hot flushes, night sweats)
  • Improving other symptoms such as low mood, decreased libido, poor sleep, joint pain
  • Reducing risk of osteoporosis in women under 60yrs (??CHECK)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

In women under 60yrs, benefits of HRT generally outweigh risks; true or false?

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

State some benefits of HRT

A
  • Improved symptoms
  • Improved QoL
  • Reduced risk of osteoporosis and fracture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

State some risks of HRT

A

Important to put risks into perspective; for women under 60yrs benefits generally outweigh risks. Certain regimes can also further reduce risks. Risks of HRT more significant in older women and increase as duration of treatment increases. Risks include:

  • Increased risk of breast cancer (particularly combined HRT; oestrogen only has little or no increased risk. Risk reduces when stop and returns to same level as other women not taking HRT by 5yrs)
  • Increased risk endometrial cancer (risk reduced by giving progesterone to women with uterus)
  • Increased risk VTE (2-3x background risk. Risk greater for oral than for transdermal)
  • Increased risk stroke (oral oestrogen but not transdermal)
  • Increased risk coronary heart disease in women >60yrs (oestrogen alone associated with no or reduced risk of CHD)
  • Evidence regarding risk of ovarian cancer inconclusive

NOTES FROM ZERO TO FINALS: These risks do not apply to all women:

  • The risks are not increased in women under 50 years compared with other women their age
  • There is no risk of endometrial cancer in women without a uterus
  • There is no increased risk of coronary artery disease with oestrogen-only HRT (the risk may even be lower with HRT)
22
Q

How can risks of HRT be reduced?

A
  • Reduce endometrial cancer risk by giving progesterone to women with uterus
  • Risk of VTE reduced by giving transdermally e.g. patches
23
Q

State some contraindications to HRT

A
  • Current, past, or suspected breast cancer.
  • Known or suspected oestrogen-dependent cancer (e.g. they have abnormal undiagnosed bleeding)
  • Untreated endometrial hyperplasia.
  • Previous idiopathic or current venous thromboembolism (deep vein thrombosis or pulmonary embolism), unless the woman is already on anticoagulant treatment.
  • Active or recent arterial thromboembolic disease (for example angina or myocardial infarction).
  • Active liver disease with abnormal liver function tests.
  • Pregnancy
  • Thrombophilic disorder
  • Uncontrolled hypertension
24
Q

What should you include in your assessment before starting someone on HRT?

A

Before initiating HRT, there are a few things to check and consider:

  • Take a full history to ensure there are no contraindications
  • Take a family history to assess the risk of oestrogen dependent cancers (e.g. breast cancer) and VTE
  • Check the body mass index (BMI) and blood pressure
  • Ensure cervical and breast screening is up to date
  • Encourage lifestyle changes that are likely to improve symptoms and reduce risks
25
Q

What factors should you consider when choosing the HRT formulation for a pt?

A
26
Q

Discuss the options for oestrogen delivery in HRT

A
  • Oral
  • Transdermal (patches or gels)

Patches more suitable if: poor control on oral treatment, higher risk VTE, cardiovascular disease or headaches

27
Q

Discuss the options for progesterone delivery in HRT

A
  • Cyclical vs continuous
    • Cyclical: give progesterone for 10-14 days per month to allow monthly breakthrough bleed
  • Different formulations:
    • Oral
    • Transdermal (patches)
    • IUS (e.g. Mirena coil)
28
Q

How long is IUS (e.g. Mirena coil) licensed for in regards to endometrial protection?

A

Licensed for 4 years for endometrial protection (needs replacing after this)

29
Q

State some benefits of using IUS (e.g. Mirena coil) as the progesterone component of combined HRT

A
  • Provides contraception
  • Treats menorrhagia
  • Won’t experience progestogenic side effects (see later FC for list of these)
30
Q

Define the following:

  • Progestogens
  • Progesterone
  • Progestins
A
  • Progestogens= any chemicals that target and stimulate progesterone receptors
  • Progesterone= the hormone produced naturally in the body
  • Progestins= synthetic progestogens
31
Q

In HRT, two progestogen classes are commonly used. State these and for each:

  • Describe situations in which they may be particularly helpful
  • State some examples
A

C19 progestogens

  • Derived from testosterone
  • “More male” hence, may be helpful for increasing libido
  • Examples: norethisterone, levonorgestrel, desogestrel

C21 progestogens

  • Derived from progesterone
  • “More female” hence, may be helpful for depressed mood & acne
  • Examples: progesterone, dydrogesterone, medroxyprogesterone
32
Q

For tibolone, discuss:

  • Mechanism of action
  • Situations in which it may be particularly helpful
  • Who can be given to and how it is given
A
  • Synthetic steroid that stimulates oestrogen & progesterone receptors (also weak stimulator of androgen receptors)
  • Since has weak stimulation of androgen receptors may be helpful for those with reduced libido
  • It is a form of continuous HRT hence women must fit criteria for continuous HRT:
    • 24 months without periods if under 50yrs
    • 12 months without periods if over 50yrs
33
Q

How long following initiation of HRT should you follow pt up?

A

3-6 months

34
Q

Side effects of HRT do not settle with time; true or false?

A

FALSE; side effects tend to settle with time so worth persisting with treatment for at least 3 months

35
Q

How long does it take for treatment to take full effect?

A

3-6 months

36
Q

What are the NICE guidelines regarding HRT and major surgery?

A

Stop oestrogen containing contraceptives or HRT 4 weeks before major surgery

37
Q

HRT acts as contraception; true or false?

A

FALSE (unless Mirena coil for progesterone component)

38
Q

Unscheduled/irregular menstrual bleeding can occur in first 3-6 months of HRT; true or false?

A

True; if continues refer for further investigations

39
Q

Side effects of HRT can be due to oestrogen or progesterone; state some oestrogenic side effects

A
  • Nausea
  • Bloating
  • Breast swelling
  • Breast tenderness
  • Headaches
  • Leg cramps
40
Q

Side effects of HRT can be due to oestrogen or progesterone; state some progestogenic side effects

A
  • Mood swings
  • Bloating
  • Fluid retention
  • Weight gain
  • Acne & greasy skin
41
Q

If pts experience side effects from HRT, what options are available?

A
  • Change type of HRT
  • Change route of HRT
42
Q

Is there any guidance around stopping HRT?

A

No; can be stopped gradually or abruptly depending on pt preference. Gradually reducing may be preferable to reduce risk of symptoms recurring suddenly

43
Q

What is atrophic vaginitis?

A

Dryness and atrophy of vaginal mucosa due to lack of oestrogen in post-menopausal women

Also referred to as ‘genitourinary syndrome or menopause’

44
Q

Discuss the pathophysiology of atrophic vaginitis

A
  • Oestrogen causes epithelial lining of vagina and urinary tract to become thicker, more elastic and produce secretions
  • During menopause, oestrogen levels decrease resulting in mucosa of vagina & urinary tract becoming thinner, less elastic and more dry
  • Consequently, tissue is more prone to inflammation
  • Can also be changes in vaginal pH and flora resulting in localised infections
  • Oestrogen also helps maintain healthy connective tissue around pelvic organs and lack of oestrogen can contribute to pelvic organ prolapse and stress incontinence
45
Q

Describe typical presentation of atrophic vaginitis

A

Post-menopausal women presenting with:

  • Dryness
  • Itching
  • Dyspareunia
  • Bleeding

May also present with recurrent UTIs, stress incontinence or pelvic organ prolapse

46
Q

What might you find on examination of pt with atrophic vaginitis?

A

Examination of the labia and vagina will demonstrate:

  • Pale mucosa
  • Thin skin
  • Reduced skin folds
  • Erythema and inflammation
  • Dryness
  • Sparse pubic hair
47
Q

Discuss the management of atrophic vaginitis

A
  • Vaginal lubricants
  • Vaginal moisturisers (e.g. Sylk, Replens, YES)
  • Topical oestrogens:
    • Estriol cream (applied using applicator)
    • Estriol pessaries
    • Estradiol tablets
    • Estradiol ring (replaced once every 3 months)

NOTE: women taking low does topical oestrogen do not need progesterone

48
Q

Are the contraindications for topical oestrogens the same as for systemic HRT?

Does long term use of topical oestrogens increase risk of endometrial hyperplasia & cancer?

A
  • Topical oestrogen shares many contraindications with systemic HRT, such as breast cancer, angina and venous thromboembolism.
  • It is unclear whether long term use of topical oestrogen increases the risk of endometrial hyperplasia and endometrial cancer. Women should be monitored at least annually, with a view of stopping treatment whenever possible.
49
Q

State some potential causes of post-menopausal bleeding- highlighting the most common one

A
  • Vaginal atrophy
  • Endometrial hyperplasia
  • Endometrial cancer
  • Endometrial polyps
  • Cervical cancer
  • Cervical polyps
  • Ovarian cancer
  • Vaginal cancer
  • Vulval cancer
  • Trauma
  • HRT
50
Q

What investigations would you do for PMB?

A

Anyone with PMB should be referred via 2WW for suspected endometrial cancer. Investigations will include:

  • Transvaginal ultrasound for endometrial thickness (normal is less than 4mm post-menopause)
  • Pipelle biopsy, which is highly sensitive for endometrial cancer making it useful for excluding cancer
  • Hysteroscopy with endometrial biopsy

*NOTE: varies between trusts but in some trusts patients with endometrial thickness <4mm and normal pipelle biopsy may be discharged.

51
Q

Discuss the management of PMB when the following causes are identified:

  • Vaginal atrophy
  • HRT
  • Endometrial hyperplasia
  • Endometrial cancer
A
  • Vaginal atrophy: topical oestrogens, vaginal lubricants, vaginal moisturisers, HRT
  • HRT: trial of different HRT preparation
  • Endometrial hyperplasia: progestogen therapy e.g. IUS, continuous oral progestogens. *NOTE: if have atypia TAH and BSO reccommended
  • Endometrial cancer: total abdominal hysterectomy with bilateral salpingo-oophorectomy (+/- chemotherapy, radiotherapy or progesterone therapy)